387 related articles for article (PubMed ID: 30413336)
1. Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Vilos AG; Oraif A; Machado M; Abu-Rafea B; Vilos GA
J Obstet Gynaecol Can; 2019 Jun; 41(6):772-781. PubMed ID: 30413336
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound diagnosis and management of acquired uterine enhanced myometrial vascularity/arteriovenous malformations.
Timor-Tritsch IE; Haynes MC; Monteagudo A; Khatib N; Kovács S
Am J Obstet Gynecol; 2016 Jun; 214(6):731.e1-731.e10. PubMed ID: 26873276
[TBL] [Abstract][Full Text] [Related]
3. Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation.
Morikawa M; Yamada T; Yamada H; Minakami H
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):751-3. PubMed ID: 17018490
[TBL] [Abstract][Full Text] [Related]
4. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
[TBL] [Abstract][Full Text] [Related]
5. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes.
Vilos AG; Vilos GA; Hollett-Caines J; Rajakumar C; Garvin G; Kozak R
Hum Reprod; 2015 Jul; 30(7):1599-605. PubMed ID: 25954037
[TBL] [Abstract][Full Text] [Related]
6. Resolution of uterine arteriovenous malformation and successful pregnancy after treatment with a gonadotropin-releasing hormone agonist.
Nonaka T; Yahata T; Kashima K; Tanaka K
Obstet Gynecol; 2011 Feb; 117(2 Pt 2):452-455. PubMed ID: 21252786
[TBL] [Abstract][Full Text] [Related]
7. A life-threatening event: uterine cervical arteriovenous malformation.
Lowenstein L; Solt I; Deutsch M; Kerner H; Amit A
Obstet Gynecol; 2004 May; 103(5 Pt 2):1073-5. PubMed ID: 15121612
[TBL] [Abstract][Full Text] [Related]
8. Uterine Arteriovenous Malformations after Suction Evacuation of Missed Miscarriage.
Javed A; Chander R; Hoodbhoy Z
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S33-S34. PubMed ID: 29482699
[TBL] [Abstract][Full Text] [Related]
9. Uterine arteriovenous malformations induced after diagnostic curettage: a systematic review.
Peitsidis P; Manolakos E; Tsekoura V; Kreienberg R; Schwentner L
Arch Gynecol Obstet; 2011 Nov; 284(5):1137-51. PubMed ID: 21904854
[TBL] [Abstract][Full Text] [Related]
10. Use of hysteroscopy in diagnosis and follow-up of acquired uterine enhanced myometrial vascularity.
Gingold JA; Bradley LD
Fertil Steril; 2020 Feb; 113(2):460-462. PubMed ID: 32106997
[TBL] [Abstract][Full Text] [Related]
11. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
12. Extensive uterine arteriovenous malformation with hemodynamic instability: Embolization for whole myometrium affection.
El Agwany AS; Elshafei M
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():188-191. PubMed ID: 29395294
[TBL] [Abstract][Full Text] [Related]
13. Uterine arteriovenous fistula necessitating hysterectomy after two unsuccessful embolizations in an 18-year-old patient.
Guo N; Liu H; Peng Z
Ann Vasc Surg; 2010 Aug; 24(6):827.e9-11. PubMed ID: 20488655
[TBL] [Abstract][Full Text] [Related]
14. The medical management of abnormal uterine bleeding in reproductive-aged women.
Bradley LD; Gueye NA
Am J Obstet Gynecol; 2016 Jan; 214(1):31-44. PubMed ID: 26254516
[TBL] [Abstract][Full Text] [Related]
15. Management of recurrent implantation failure by gonadotropin-releasing hormone agonist and aromatase inhibitor suppression, in women without evidence of endometriosis.
Khayat S; Elliott B; Dahan MH
Gynecol Endocrinol; 2019 Mar; 35(3):267-270. PubMed ID: 30328740
[TBL] [Abstract][Full Text] [Related]
16. Fertility, Pregnancy, and Clinical Outcomes after Uterine Arteriovenous Malformation Management.
Delplanque S; Le Lous M; Proisy M; Joueidi Y; Bauville E; Rozel C; Beraud E; Bruneau B; Levêque J; Lavoué V; Nyangoh Timoh K
J Minim Invasive Gynecol; 2019 Jan; 26(1):153-161. PubMed ID: 29772406
[TBL] [Abstract][Full Text] [Related]
17. Endometrial ablation in the management of abnormal uterine bleeding.
Laberge P; Leyland N; Murji A; Fortin C; Martyn P; Vilos G; ; Leyland N; Wolfman W; Allaire C; Awadalla A; Dunn S; Heywood M; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh S; Yeung G;
J Obstet Gynaecol Can; 2015 Apr; 37(4):362-79. PubMed ID: 26001691
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations.
Picel AC; Koo SJ; Roberts AC
Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1170-6. PubMed ID: 27021069
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and management of uterine arteriovenous fistula with massive vaginal bleeding].
Yang JJ; Xiang Y; Wan XR; Gao Y; Cheng NH; Liu W; Yang N; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):797-800. PubMed ID: 15733402
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Ligation of Uterine Vasculature for Fertility-Sparing Management of Postabortal Hemorrhage.
Menderes G; Leon-Martinez D; Azodi M
J Minim Invasive Gynecol; 2019 Jan; 26(1):36-37. PubMed ID: 29609031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
